Alec, why don't you pay attention finalizing the contract with Sony? Perhaps if you weren't so obsessed with those folks in bed "D", this company could move forward. Just trying to help you here after all these years with your strange taste for pleasure. Maybe you could find a real WOMAN with facial hair and a deep throaty voice to ease you back into the real world. If you've already gone that route and it hasn't worked, it is OK. We will accept you the way you are. And it is Christmas, so I'm sure I speak for the entire board in wishing you and your friends in bed D the very best. Happy Holidays.
Nicely put. We are struggling at less than $2 because nobody will take Tokman's word about anything any more. Positive proof in the form of contracts signed is all that the street is willing to accept. One product introduction by a name will get the attention and forecasts needed to move the pps and then the bean counters will see the no debt and tax loss going forward and we will MOVE.
Agree with all and focus on the 500+ and il-12 and il-33. What is sorely needed is partnerships with the big guys that bring their own adjuvants to us along with their cash. I am of the opinion that all 500+ patents we have will be greatly enhanced with added adjuvants and big pharma has more experience there than we do.
A great year for introducing our tech as we have several started and more in the starting gate. All of that means money, and that is holding us back. It will take longer to market if we start an indication and later add to it another adjuvant. FDA is pretty solid when changing a drug in trial and starting over is not a wanted result. Very interested to see 3112 results. That will confirm my thinking that almost all of our patents need something else added to the equation for super results.
Wait for CES on Jan.6th. First time I'll be getting info straight from the floor. Looking at Sony more than MVIS booths. The secret is with Sony and that's where our focus is for the show. Holding or selling at this point and how much will depend on Sony, not Tokman and gang.
You make a bold call today, Vant can make one tomorrow, and I'll make one on Friday. Sooner or later one of us will get this ball rolling.
Sure is nice to see some of these retail investors have a head on their shoulders. I have stated this many times to the jerks that want to go it alone and keep all the profits. Clear runway to 2017, we don't need any partners drives me crazy. Just left my Doctors office an hour ago and we discussed biotech and vaccines in particular. He was well aware of all that is going on in the space but didn't know of INO in particular although it is fairly local. What he told me was that the science has a lot of hurdles to overcome and unless a company has a product in the market they will soak up money like a sponge and partnerships are key. He mentioned exactly what you said about checkpoint inhibitors and how important it is to partner. We couldn't talk longer as patients were waiting, but he was interested enough for sure. I can't believe the investors know so little about the difficulties of finding good partners and building relationships. Oh, and his last words were, "if they are proven in early trials, they will be bought. Big pharma won't shell out the 100B or so for P3 trials. They will let the little guys fund them and then buy the company as cheap as they can".
Anybody see an Airpico or a Picoair anywhere? How about a contract of sorts? No? Well I guess we still have a few days left. Was thinking that if a contract doesn't come this week he might as well save it because the volume will be pretty light from Monday through the end of the year and we would get a muted response. Alec is still batting a thousand. What are the chances that he misses CES as well? Hate to go out there and spend all that money to find MVIS just missed another timeline. Sounds like business as usual in Redmond.
Thanks micro, I knew somebody would be up to par on this. Have to relay that back to my friend that got that info for me.
Yep, it is a big Midwest Hospital and I figured if they are training their staff in its use it has to be making big strides. Would like to see us get a start.
Wish he would get one right for us, just once. Two weeks left in the year and we need one to keep it from falling big again. Had hoped a contract would ease the dilution hanging over us. He did lead us to believe that we would see one by the end of the year, so it is raised expectations by the company and not the pumpers. All the buying we've done has been on his words, and he hasn't gained any credibility so far, at least not with me. In all fairness, this has been a good year from a prospective stand point, but we still face many hurdles and we don't know if he has the ability to sit at the same table with the likes of a Sony and walk away with his underwear still on. This song gets real old.
Nobody knows huh. Just thought I would ask because I was informed today that a big hospital is starting to train their nurses with it. I did see patents issued to them and Microvision and wondered if we were still being used in their product. Thought a tie in to the latest component order was there. Just a thought. Too early for UPS I think.
I would worry more about Tokman and company taking a buyout offer and leaving the shareholders sucking wind. They have taken care of themselves for the past ten years on the backs of shareholders and the BOD hasn't done much in terms of support in the form of share purchases. An offer on the back of a quick homerun with plenty more on the horizon would bring several offers in my opinion. Would Tokman and the BOD take the easy way out? Something to think about. I'll get a lot of criticism for that, but his record so far is quite clear as far as supporting shareholders.